Editorial Commentary
Patient centered care for prostate cancer—how can artificial intelligence and machine learning help make the right decision for the right patient?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S1
(March 2019)
Meningeal lymphatics in aging and Alzheimer’s disease
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S2
(March 2019)
Pembrolizumab in advanced gastric cancer: pioneering or prosaic?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S3
(March 2019)
Improving detection combined with targeted therapy for small hepatocellular carcinoma
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S4
(March 2019)
Is the onset of adverse effects of immunotherapy always bad news for the patients…?—certainly not!
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S5
(March 2019)
Fluorescence-guided surgery in cancer treatment: current status and future perspectives
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S6
(March 2019)
Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S7
(March 2019)
Pathophysiology of pain in patients with peritoneal endometriosis
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S8
(March 2019)
Lessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironment
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S9
(March 2019)
American Joint Committee on Cancer 8th edition staging—an improvement in prognostication in HPV-associated oropharyngeal cancer?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S10
(March 2019)
Eighth edition of the American Joint Committee on Cancer staging system for soft tissue sarcoma of the trunk and extremity: in search of a better staging system
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S11
(March 2019)
Cancer staging for rare cancers: should the American Joint Committee on Cancer have a separate staging classification for external auditory canal cancer?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S12
(March 2019)
Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light—it is mitochondrial bound water: the principles of low-level light therapy
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S13
(March 2019)
Pembrolizumab for recurrent/metastatic head and neck cancer: equally promising for Asian patients?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S14
(March 2019)
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S15
(March 2019)
Ultrasound patterns of pulmonary edema
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S16
(March 2019)
There is another new method for cryopreserving small numbers of human sperm cells
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S17
(March 2019)
Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S18
(March 2019)
Monocyte-platelet cross-talk in peripheral artery disease—how much does the pathogenesis of atherosclerosis depend on anatomical location?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S19
(March 2019)
The variables of force generation and application to cartilage, ligaments and bone remain to be defined
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S20
(March 2019)
Orphan noncoding RNAs: novel regulators and cancer biomarkers
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S21
(March 2019)
Immunotherapeutic strategies in patients with advanced head and neck squamous cell carcinoma
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S22
(March 2019)
Important caveats of KEYNOTE-045: relevance of these findings in the current and future therapeutic paradigm
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S23
(March 2019)
The use of baseline tumor size to prognosticate overall survival in stage IV melanoma patients treated with the PD-1 inhibitor pembrolizumab
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S24
(March 2019)
Norepinephrine, more than a vasopressor
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S25
(March 2019)
A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy: an editorial comment
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S26
(March 2019)
Electronic health records, physician workflows and system change: defining a pathway to better healthcare
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S27
(March 2019)
Nephron repair: powered by anaerobic energy metabolism
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S28
(March 2019)
Nanoparticles as theranostic vehicles in prostate cancer
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S29
(March 2019)
Mind the gap: renal tubule responses to injury and the role of Cxcl12 and Myc
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S30
(March 2019)
Anterior knee pain as a functional problem of complex dynamic inter-play of living structures
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S31
(March 2019)
Is an immune checkpoint inhibitor really a hopeless therapeutic choice for EGFR-mutant non-small cell lung cancer (NSCLC) patients?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S32
(March 2019)
Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S33
(March 2019)
Anatomy is not enough: the crucial role of biology and genetics in AJCC eighth edition of the TNM classification for breast cancer
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S34
(March 2019)
When survival curves cross: are we at a crossroads of immunotherapy in gastric cancer?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S35
(March 2019)
Editorial on “Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era”
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S36
(March 2019)
The potential role of germline single nucleotide polymorphisms for selecting the ideal candidates for sunitinib therapy in patients with locally-advanced renal cell carcinoma
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S37
(March 2019)
Adjuvant therapy in renal cell carcinoma—is pharmacogenomics assessment another element to select our patients?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S38
(March 2019)
Optimizing renal function and outcome of patients with cT2 renal cell carcinoma
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S39
(March 2019)
Stem cell therapy in diabetic men with erectile dysfunction: a step closer to safe and effective regenerative technology
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S40
(March 2019)
UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classifications for patients treated with radical prostatectomy: reliable but not infallible prognostic tools
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S41
(March 2019)
Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S42
(March 2019)
Fine-tuning autophagy in pancreatic adenocarcinoma: full blockage is required
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S43
(March 2019)
Is smoking causally-associated with hepatitis B virus-related hepatocellular carcinoma?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S44
(March 2019)
Predicting renal function after kidney cancer surgery: a tool for clinical decision making
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S45
(March 2019)
Potential biological and clinical benefit of prostate-directed interventions in patients with metastatic prostate cancer
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S46
(March 2019)
What is the most durable construct for a forefoot amputation, traditional transmetatarsal amputation or a medial ray sparing procedure?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S47
(March 2019)
Systemic therapy of elderly patients with advanced non-small cell lung cancer—individualized treatment is key
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S48
(March 2019)
Thyroid cancer staging and genomics
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S49
(March 2019)
Encouraging early outcomes in cancer and leukemia group B (CALGB)/Alliance 140503: patient selection, not extent of resection, is the key to perioperative success
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S50
(March 2019)
Implementation of staging systems in clinical practice for cutaneous squamous cell carcinoma
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S51
(March 2019)
Eighth edition of the American Joint Committee on Cancer staging system: are we getting closer to the ideal classification for gastric cancer?
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S52
(March 2019)
An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S53
(March 2019)
Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptions
Annals of Translational Medicine
2019;
7
(Suppl 1)
:S54
(March 2019)
Disclosure:
The supplement was published without any sponsorship or funding.
